Director,Human Genome Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 57 board members in 5 different organizations across 6 different industries.|
See Board Relationships
Mr. Adrian Rawcliffe, also known as Ad, has been the Chief Financial Officer of Adaptimmune Therapeutics plc since March 16, 2015 and serves as its Principal Accounting Officer. Mr. Rawcliffe leads financial strategy, management and operations functions including compliance and risk management. He served as the Chief Financial Officer of Human Genome Sciences Inc. since August 2012. He has 17 years of experience within the pharmaceutical industry and also served as ...
14200 Shady Grove RoadPhone: 301-309-8504
Rockville, Maryland 20850-7464
Board Members Memberships*
Annual Compensation*There is no Annual Compensation data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Randal J. Kirk J.D.||Chairman and Chief Executive Officer|
|$4.4M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.